NCT00858702

Calcium Channel Blockers (CCBs) or Diuretics as an Add-on to Olmesartan Medoxomil in Hypertension

Add-on Study of CCBs or Diuretics in Essential Hypertension Not Achieving Target Blood Pressure on Olmesartan Medoxomil Alone

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 105 (actual)
• Sponsor: Daiichi Sankyo Co., Ltd. · Industry
• Sex: All
• Age: 20 Years – 74 Years
• Healthy volunteers: Not accepted

Summary

The purpose of the study is to test the efficacy and safety of the combination of Calcium Channel Blockers (CCBs)(of the dihydropyridine class) or Diuretics (of the thiazide class) and olmesartan medoxomil in essential hypertensive patients whose blood pressure is not adequately controlled with olmesartan medoxomil alone

Conditions

• Hypertension

Interventions

Type	Name	Description
DRUG	olmesartan medoxomil and a CCB	olmesartan medoxomil tablets and a CCB tablet once daily for 8 weeks
DRUG	olmesartan medoxomil and a diuretic	olmesartan medoxomil tablets and a diuretic tablet, once daily for 8 weeks

Timeline

• Start date: 2005-02-01
• Primary completion: 2005-07-01
• Completion: 2005-11-01
• First posted: 2009-03-10
• Last updated: 2017-10-11
• Results posted: 2009-08-26

Locations

1 site across 1 country: Japan